WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Stock Ownership - Who owns Innoviva?

Insider buying vs selling

Have Innoviva Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Matthew RonsheimOfficer2024-02-20807$15.80
$12.75kSell
Marianne ZhenChief Accounting Officer2024-02-202,862$15.80
$45.22kSell
Matthew RonsheimOfficer2024-01-181,600$16.05
$25.68kSell
Marianne ZhenChief Accounting Officer2023-11-20784$13.62
$10.68kSell
Marianne ZhenChief Accounting Officer2023-11-155,405$13.97
$75.51kSell
Marianne ZhenChief Accounting Officer2023-11-155,589$14.01
$78.30kSell
Marianne ZhenChief Accounting Officer2023-08-18785$13.64
$10.71kSell
Alexander J. Denner10% Owner2023-06-1562,000$13.13
$814.18kBuy
Alexander J. Denner10% Owner2023-06-068,000$13.05
$104.38kBuy
Alexander J. Denner10% Owner2023-06-057,000$13.04
$91.29kBuy

1 of 3

INVA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INVA insiders and whales buy or sell their stock.

INVA Shareholders

What type of owners hold Innoviva Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Glaxosmithkline PLC49.94%32,005,260$491.92MInsider
Blackrock Inc16.15%10,352,073$159.11MInstitution
Alexander J. Denner11.35%7,277,000$111.85MInsider
Sarissa Capital Management LP11.35%7,277,000$111.85MInstitution
Vanguard Group Inc10.47%6,712,443$103.17MInstitution
Putnam Investments LLC9.78%6,270,413$96.38MInstitution
Dimensional Fund Advisors LP7.05%4,516,999$69.43MInstitution
Renaissance Technologies LLC6.47%4,144,447$63.70MInstitution
Jeffrey M. Drazan4.52%2,893,921$44.48MInsider
Westfield Capital Management Co LP4.08%2,614,127$40.18MInstitution

1 of 3

INVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INVA58.69%41.31%Net BuyingNet Selling
CABA92.00%8.00%Net BuyingNet Buying
EYPT20.59%79.41%Net SellingNet Selling
PHVS99.42%0.00%
SLN17.71%0.00%

Innoviva Stock Ownership FAQ

Who owns Innoviva?

Innoviva (NASDAQ: INVA) is owned by 113.03% institutional shareholders, 79.57% Innoviva insiders, and 0.00% retail investors. Glaxosmithkline PLC is the largest individual Innoviva shareholder, owning 32.01M shares representing 49.94% of the company. Glaxosmithkline PLC's Innoviva shares are currently valued at $491.28M.

If you're new to stock investing, here's how to buy Innoviva stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.